智醫科學

AI醫療技術、應用與市場動態

【新冠】利用血液生物標記和機器學習,預測COVID-19患者的再入院率

 【新冠】利用血液生物標記和機器學習,預測COVID-19患者的再入院率


 文章出處  

Frontiers in Medicine 

 

 原文標題  

Forecasting Readmission in COVID-19 Patients Utilizing Blood Biomarkers and Machine Learning within the Hospital-at-Home (HaH) Program 

 

 文章序號  

7517 

 

智醫科學-AI醫療技術、應用與市場動

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.